2m 2m 2m 2m 2m 2m 2m
Harrow (HROW)
NASDAQ
$33.23+$0.37 (+1.11%)
Price as of Jun 03, 2026 6:09 PM EDT- $1.3BMarket Cap
- 12.00%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Harrow (HROW)
$33.23+$0.37 (+1.11%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | N/A N/A | 3.1M -97.63% | 130.2M +46.95% | 88.6M +22.24% | |
Cost of Revenue | 67.9M +37.95% | 49.2M +24.23% | 39.6M +56.17% | 25.4M +39.36% | |
Gross Profit | 204.4M +35.91% | 150.4M +66.06% | 90.6M +43.25% | 63.2M +16.49% | |
Sales and Marketing Expense | 152.9M +18.48% | 129.1M +55.33% | 83.1M +42.66% | 58.2M +40.97% | |
Research and Development Expense | -20.9M +71.22% | -12.2M +83.85% | -6.7M +118.10% | -3.0M -72.48% | |
Depreciation and Amortization Expense | 1.9M +3.51% | 1.9M +20.92% | 1.5M +3.59% | 1.5M -13.98% | |
Total Operating Expenses | 173.9M +22.82% | 141.5M +57.06% | 90.1M +47.03% | 61.3M +16.42% | |
Operating Profit | 30.5M +245.90% | 8.8M +1,946.87% | 431,000 -77.54% | 1.9M +18.90% | |
Interest Income | N/A N/A | -3.2M -202.55% | 3.1M +206.11% | -2.9M -71.22% | |
Interest Expense | N/A N/A | N/A N/A | -21.3M +194.37% | -7.2M +33.26% | |
Interest Income and Expense and Net | 0 +100.00% | -3.2M -82.61% | -18.2M +79.48% | -10.2M -34.73% | |
Total Nonoperating Income and Expense | -31.9M +21.96% | -26.1M +8.29% | -24.1M +51.54% | -15.9M -18.26% | |
Income before Taxes | -1.4M -92.10% | -17.3M -26.95% | -23.7M +69.22% | -14.0M -21.61% | |
Income Taxes | 3.8M +2,242.24% | 161,000 -77.03% | 701,000 +834.67% | 75,000 -43.61% | |
Extraordinary Items | 0 N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | N/A N/A | -17.5M -28.39% | -24.4M +73.30% | -14.1M -21.77% | |
Net Income from Continuing Operations Applicable to Common | -1.4M -92.10% | -17.3M -26.95% | -23.7M +68.32% | -14.1M -23.77% | |
Basic EPS and Net Income | -0.14 -71.43% | -0.49 -34.67% | -0.75 +47.06% | -0.51 -26.09% | |
Diluted EPS and Net Income | -0.14 -71.43% | -0.49 -34.67% | -0.75 +47.06% | -0.51 -26.09% | |
Basic Weighted Average Shares | 36.8M +3.11% | 35.7M +9.30% | 32.6M +18.78% | 27.5M +2.63% | |
Diluted Weighted Average Shares | 36.8M +3.11% | 35.7M +9.30% | 32.6M +18.78% | 27.5M +2.63% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 72.9M +54.35% | 47.2M -36.23% | 74.1M -23.04% | 96.3M +128.31% | |
Short-Term Investments | N/A N/A | N/A N/A | 8.7M +55.32% | 5.6M N/A | |
Cash and Cash Equivalents and Short-Term Investments | 72.9M +54.35% | 47.2M -42.91% | 82.8M -18.74% | 101.9M +141.56% | |
Total Current Assets | 211.8M +11.65% | 189.7M +35.97% | 139.5M +17.95% | 118.3M +94.95% | |
Accumulated Depreciation | 12.2M +10.99% | 11.0M +9.35% | 10.1M +11.16% | 9.1M +15.68% | |
Property and Plant and Equipment and Net | 3.3M -12.69% | 3.7M +6.05% | 3.5M +1.00% | 3.5M +10.98% | |
Total Long-Term Assets | 3.3M -12.69% | 3.7M +6.05% | 3.5M +1.00% | 3.5M +10.98% | |
Total Assets | 399.5M +2.70% | 389.0M +24.60% | 312.2M +98.35% | 157.4M +60.05% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | 453,000 N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 96.3M +5.43% | 91.3M +85.11% | 49.3M +164.83% | 18.6M +91.65% | |
Total Long-Term Debt | 243.2M +10.77% | 219.5M +19.85% | 183.2M +75.83% | 104.2M +45.38% | |
Total Long-Term Liabilities | 251.1M +9.97% | 228.3M +20.37% | 189.7M +70.12% | 111.5M +43.57% | |
Total Liabilities | 347.4M +8.67% | 319.7M +32.23% | 241.8M +85.77% | 130.1M +48.90% | |
Retained Earnings | -156.5M +3.39% | -151.4M +13.05% | -133.9M +22.29% | -109.5M +14.76% | |
Total Stockholders Equity | 52.4M -24.70% | 69.7M -1.57% | 70.8M +156.45% | 27.6M +144.51% | |
Total Shares Outstanding | 37.2M +4.51% | 35.6M +1.29% | 35.2M +17.61% | 29.9M +11.15% | |
Cash Flow | |||||
Cash from Operating Activities | 43.9M +297.57% | -22.2M -678.18% | 3.8M +125.22% | 1.7M -66.45% | |
Capital Expenditures | 887,000 -44.39% | 1.6M +9.25% | 1.5M -43.78% | 2.6M +45.41% | |
Cash from Investing Activities | -5.5M -83.54% | -33.2M -78.26% | -152.6M +8,652.32% | -1.7M -90.67% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -12.7M -144.60% | 28.5M -77.45% | 126.5M +133.70% | 54.1M +5.19% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | -1,492.66% -2,246.08% | 69.55% -2.52% | 71.35% -4.70% | |
Operating Margin | N/A N/A | 285.32% +86,098.46% | 0.33% -84.72% | 2.17% -2.73% | |
Return on Assets | N/A N/A | -4.99% -52.04% | -10.40% -5.62% | -11.02% -52.34% | |
Return on Equity | N/A N/A | -24.90% -49.84% | -49.64% -31.50% | -72.46% -22.60% | |
Revenue Growth | N/A N/A | -97.63% -307.92% | 46.95% +111.11% | 22.24% -53.95% | |
Current Ratio | 2.20 +5.90% | 2.08 -26.55% | 2.83 -55.46% | 6.35 +1.72% | |
Cash Ratio | 0.76 +46.42% | 0.52 -65.55% | 1.50 -70.94% | 5.17 +19.13% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow